BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12835514)

  • 1. A study on telomerase activity and prognosis in breast cancer.
    Kimura M; Koida T; Yanagita Y
    Med Oncol; 2003; 20(2):117-26. PubMed ID: 12835514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and survival of patients with node-positive breast cancer.
    Clark GM; Osborne CK; Levitt D; Wu F; Kim NW
    J Natl Cancer Inst; 1997 Dec; 89(24):1874-81. PubMed ID: 9414175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
    He GP; Shui QL; Huang Y; Zhang SZ; Yu H
    Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype.
    Kulić A; Plavetić ND; Gamulin S; Jakić-Razumović J; Vrbanec D; Sirotković-Skerlev M
    Med Oncol; 2016 Mar; 33(3):23. PubMed ID: 26833480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity and prognosis in primary breast cancers.
    Carey LA; Kim NW; Goodman S; Marks J; Henderson G; Umbricht CB; Dome JS; Dooley W; Amshey SR; Sukumar S
    J Clin Oncol; 1999 Oct; 17(10):3075-81. PubMed ID: 10506602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
    Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
    Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
    Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
    IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
    Bautista CV; Felis CP; Espinet JM; García JB; Salas JV
    Dis Colon Rectum; 2007 May; 50(5):611-20. PubMed ID: 17297554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
    Pinto AE; André S; Pereira T; Silva G; Soares J
    Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and prognosis in breast cancer.
    Mokbel K; Parris CN; Radbourne R; Ghilchik M; Newbold RF
    Eur J Surg Oncol; 1999 Jun; 25(3):269-72. PubMed ID: 10336806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
    Mueller C; Riese U; Kosmehl H; Dahse R; Claussen U; Ernst G
    Int J Oncol; 2002 Feb; 20(2):385-90. PubMed ID: 11788906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomerase activity in breast carcinoma].
    Yang W; Xu L; Zhang T
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):278-80. PubMed ID: 11776815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase and breast cancer: from diagnosis to therapy.
    Mokbel K; Williams NJ
    Int J Surg Investig; 2000; 2(1):85-8. PubMed ID: 12774343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in central nervous system malignant lymphoma.
    Harada K; Kurisu K; Arita K; Sadatomo T; Tahara H; Tahara E; Ide T; Uozumi T
    Cancer; 1999 Sep; 86(6):1050-5. PubMed ID: 10491533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables.
    Kalogeraki A; Kafousi M; Ieromonachou P; Giannikaki E; Vrekoussis T; Zoras O; Tsiftsis D; Stathopoulos E
    Anticancer Res; 2005; 25(3B):1927-30. PubMed ID: 16158927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
    Miyachi K; Fujita M; Tanaka N; Sasaki K; Sunagawa M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):269-75. PubMed ID: 12148588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of reactivation of telomerase in breast core biopsy specimens.
    Herbert GS; Sohn VY; Mulcahy MJ; Champeaux AL; Brown TA
    Am J Surg; 2007 May; 193(5):547-50; discussion 550. PubMed ID: 17434352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of telomerase activity in patients with brain tumors.
    Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
    J Korean Med Sci; 2006 Feb; 21(1):126-30. PubMed ID: 16479078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.